BR9904109A - Genes reguladores de streptomyces avermitilis para aumento de produção de avermectina - Google Patents

Genes reguladores de streptomyces avermitilis para aumento de produção de avermectina

Info

Publication number
BR9904109A
BR9904109A BR9904109-0A BR9904109A BR9904109A BR 9904109 A BR9904109 A BR 9904109A BR 9904109 A BR9904109 A BR 9904109A BR 9904109 A BR9904109 A BR 9904109A
Authority
BR
Brazil
Prior art keywords
avermectin
genes
streptomyces avermitilis
increase
avermectin production
Prior art date
Application number
BR9904109-0A
Other languages
English (en)
Inventor
Kim Jonelle Stutzman-Engwall
Brenda Sue Price
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9904109A publication Critical patent/BR9904109A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"GENES REGULADORES DE STREPTOMYCES AVERMITILIS PARA AUMENTO DE PRODUçãO DE AVERMECTINA"<D>. A presente invenção refere-se a composições e métodos para produzir avermectinas, e é essencial no campo da saúde animal. A presente invenção refere-se com à identificação e caracterização de dois novos genes, aqui referidos como os genes aveR1 e aveR2, que estão implicados na regulação da expressão de avermectina policetido sintase (PKS) e na biossíntese de avermectina em Streptomyces avermitilis. A presente invenção é baseada na descoberta de que a inativação destes genes resulta em um aumento da quantidade de produção de avermectina por S.avermitilis.
BR9904109-0A 1998-09-14 1999-09-14 Genes reguladores de streptomyces avermitilis para aumento de produção de avermectina BR9904109A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10013498P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
BR9904109A true BR9904109A (pt) 2000-10-17

Family

ID=22278261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9904109-0A BR9904109A (pt) 1998-09-14 1999-09-14 Genes reguladores de streptomyces avermitilis para aumento de produção de avermectina

Country Status (17)

Country Link
US (2) US6197591B1 (pt)
EP (1) EP0997528A1 (pt)
JP (1) JP3595210B2 (pt)
KR (1) KR100343357B1 (pt)
CN (1) CN1252440A (pt)
AR (1) AR021485A1 (pt)
AU (1) AU758329B2 (pt)
BR (1) BR9904109A (pt)
CA (1) CA2281935A1 (pt)
HU (1) HUP9903073A3 (pt)
ID (1) ID23542A (pt)
IL (1) IL131845A0 (pt)
IN (1) IN190976B (pt)
PL (1) PL335438A1 (pt)
RU (1) RU2221042C2 (pt)
TR (1) TR199902239A2 (pt)
ZA (1) ZA995872B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720415B2 (en) * 1998-12-02 2004-04-13 Princeton University Compositions and methods for regulating bacterial pathogenesis
US7326542B2 (en) * 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
CA2402398A1 (en) * 2000-02-24 2001-08-30 Kyowa Hakko Kogyo Co., Ltd. Process for producing avermectin derivative
US6559176B1 (en) 2000-05-10 2003-05-06 Princeton University Compounds and methods for regulating bacterial growth and pathogenesis
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
IL162866A0 (en) * 2002-02-12 2005-11-20 Pfizer Prod Inc Streptomyces a vermitilis gene directing the ratioof b2:b1 avermectins
US7326782B2 (en) * 2003-08-21 2008-02-05 Wisconsin Alumni Research Foundation Metabolic engineering of viomycin biosynthesis
US7645600B2 (en) * 2004-07-23 2010-01-12 Shin-Etsu Chemical Co., Ltd. Compositions and methods for enhanced bacterial exopolysaccharide production
KR100564156B1 (ko) * 2004-08-23 2006-03-24 주식회사 진켐 스트렙토마이세스 푸세티우스 유래 전사활성체 및 그 유전자
JP2006296419A (ja) * 2005-03-04 2006-11-02 Hiroshima Univ 遺伝子破壊による抗生物質産生微生物の生産方法およびこれを用いて得られる抗生物質産生微生物、並びに抗生物質代謝中間体の生産方法
KR20140001229A (ko) * 2007-03-30 2014-01-06 아보트 러보러터리즈 숙주 세포에서 재조합 단백질의 발현을 증강시키기 위한 재조합 발현 벡터 요소(ｒＥＶＥ)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4362816A (en) 1980-11-13 1982-12-07 The Upjohn Company Hybrid plasmid and process of making same
US4898828A (en) 1985-08-07 1990-02-06 Eli Lilly And Company Ultrahigh copy number streptomycetes plasmids
US5242809A (en) 1986-02-28 1993-09-07 Smithkline Beecham Corporation Gal operon of streptomyces
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
ES2054822T3 (es) 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
DE3825615A1 (de) * 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
US5264354A (en) 1988-09-30 1993-11-23 Eli Lilly And Company Method for isolating transposable elements from streptomyces
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
EP0391594B1 (en) 1989-03-31 1995-10-18 Merck & Co. Inc. Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
US5122595A (en) 1989-05-19 1992-06-16 Applied Research Systems Ars Holding N.V. SAF polypeptide gene coding therefor, and SAF promoter
US5118617A (en) 1989-05-19 1992-06-02 Applied Research Systems Ars Holding N.V. Saf polypeptide, gene coding therefor, saf promoter and expression methods for expressing foreign dna sequences in streptomyces
BR9407211A (pt) 1993-07-30 1996-09-17 Pfizer Genes codificadores do complexo de desidrogenase de alfa- cetoácidos de cadeia ramificada derivados de streptomyces avermitilis
FI942725A (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
US5474912A (en) 1994-03-03 1995-12-12 Sherman; David H. Method for increasing production of microbial metabolites by genetic engineering
US5876987A (en) 1996-02-07 1999-03-02 Board Of Trustees Operating Michigan State University Method, DNA and bacteria for hyperproduction of an antibiotic due to disruption of an AbsA gene

Also Published As

Publication number Publication date
EP0997528A1 (en) 2000-05-03
JP2000102394A (ja) 2000-04-11
AU758329B2 (en) 2003-03-20
AR021485A1 (es) 2002-07-24
ID23542A (id) 2000-05-04
IN190976B (pt) 2003-09-06
US6689611B1 (en) 2004-02-10
CN1252440A (zh) 2000-05-10
AU4757599A (en) 2000-03-23
HU9903073D0 (en) 1999-11-29
RU2221042C2 (ru) 2004-01-10
KR20000023111A (ko) 2000-04-25
HUP9903073A2 (en) 2000-07-28
ZA995872B (en) 2001-03-13
KR100343357B1 (ko) 2002-07-15
CA2281935A1 (en) 2000-03-14
TR199902239A2 (xx) 2000-04-21
HUP9903073A3 (en) 2005-05-30
IL131845A0 (en) 2001-03-19
JP3595210B2 (ja) 2004-12-02
US6197591B1 (en) 2001-03-06
PL335438A1 (en) 2000-03-27

Similar Documents

Publication Publication Date Title
Kanwal et al. Dietary flavones as dual inhibitors of DNA methyltransferases and histone methyltransferases
Stefanska et al. Epigenetic mechanisms in anti‐cancer actions of bioactive food components–the implications in cancer prevention
BR9904109A (pt) Genes reguladores de streptomyces avermitilis para aumento de produção de avermectina
HK1146410A1 (en) 2&#39;-fluoro-2&#39;-deoxytetrahydrouridines as cytidine deaminase inhibitors
BRPI0606324A2 (pt) derivados de purina agindo como agonistas de receptor de a2a
BRPI0514342A2 (pt) molécula de rna de filamento duplo, agrupamento de moléculas de rna de filamento duplo, planta transgênica, e, métodos para controlar a infecção de uma planta por um nematóide parasìtico e para fabricar uma planta transgênica
MX2019005816A (es) Agentes de arn modificados con efecto reducido fuera de la diana.
BR112021019793A2 (pt) Composições e métodos para inibir expressão de gene no sistema nervoso central
BR9910729A (pt) Regulação mediada por dsrna de expressão de gene em plantas
BRPI0410886A (pt) composto de filamento duplo, composição farmacêutica, sal farmaceuticamente aceitável, métodos de modificação do ácido nucleico que codifica a survivina humana, de inibição da expressão da suvivina em células ou tecidos, e de tratamento de uma condição associada com a expressão ou superexpressão da suvivina, e, oligonucleotìdeo de rnai de filamento único
ME01285A (me) Derivati dioksa-bicikl0[3.2.1]oktan-2,3,4-triola
MX2010002027A (es) Derivados de bencilbenceno y metodos de uso.
BRPI0517613A (pt) oligonucleotìdeos lna e tratamento de cáncer
BRPI0515994A (pt) biossìntese de floroglucinol e preparo de 1, 3-dihidróxibenzeno a partir do mesmo
BR112015000710A8 (pt) Oligonucleotídeos para fazer uma alteração na sequência de um presente alvo de molécula de rna em uma célula viva
BRPI0813127A8 (pt) Rosa contendo flavona e malvidina e método para produção da mesma
BRPI0517455A (pt) compostos orgánicos
NO20085099L (no) Puritonderivativer som HM74A agonister
BRPI0413353A (pt) composição farmacêutica contendo droga solúvel em água
BRPI0410391A (pt) derivados (2-hidróxi-2-(4-hidróxi-3-hidroximetilfenil)-etilamino)- propilfenila como agonistas beta2
Zaman et al. Protein kinase CK2 is involved in zinc homeostasis in breast and prostate cancer cells
MX2023008469A (es) Oligonucleotidos de doble hebra modificados.
BR0008297A (pt) Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma
BRPI0408389A (pt) derivados de cromeno como agentes antiinflamatórios
Biswas et al. Deep sequencing unravels methyl jasmonate responsive novel miRNAs in Podophyllum hexandrum

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.